© Globe Newswire
16.01.2026
DBV
LISTED
EURONEXT
DBV Technologies Announces €166.7 Million in Gross Proceeds Following the Full Exercise of the ABSA Warrants and BS Warrants Issued on its March 2025 Financing
News Preview
Châtillon, France, January 16, 2026...
Themefolio
Profiler
Peergroup
© BusinessWire
16.01.2026
BAYN
LISTED
XETR
Bayer welcomes the U.S. Supreme Court decision to review the Durnell case in the Roundup™ litigation
News Preview
The U.S. Supreme Court today announced that it will review the Durnell Roundup™ case. Monsanto petitioned the court to hear Durnell in April 2025 and address the split in authority among federal circuit courts on the application of federal preemption, a cross-cutting issue in the Roundup™ litigation. The company expects a decision on the merits du...
Themefolio
Profiler
Peergroup
© Globe Newswire
16.01.2026
GMAB
LISTED
CPH
Genmab Announces Topline Results for Epcoritamab (DuoBody® CD3xCD20) from Phase 3 EPCORE® DLBCL-1 Trial in Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL)
News Preview
Company Announcement...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Short sale statistics, hedge fund activities and much more user-friendly information
© Globe Newswire
16.01.2026
AGFB
LISTED
EURONEXT
Agfa receives final expert ruling on receivable related to sale of Offset Solutions division to Aurelius
News Preview
...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© BusinessWire
16.01.2026
ERF
LISTED
EURONEXT
Eurofins Scientific: Director/PDMR Shareholding
News Preview
Eurofins Scientific SE (EUFI.PA) (Paris:ERF) has received various notifications of dealing from Persons Discharging Managerial Responsibilities (“PDMR”). The notification of Dealing Form for each PDMR can be found below.
This notification is made in accordance with the European Market Abuse Regulation.
NOTIFICATION AND PUBLIC DISCLOSURE OF T...
Themefolio
Profiler
Peergroup
© PR Newswire
16.01.2026
SOBI
LISTED
STO
Sobi Receives European Commission Approval for Aspaveli® (pegcetacoplan) for the Treatment of C3G and Primary IC-MPGN
News Preview
Approximately 8,000 people in Europe are living with C3G or primary IC-MPGN Aspaveli (pegcetacoplan) is the first treatment of primary IC-MPGN and the first treatment for C3G and primary IC-MPGN for patients 12 years and olderSTOCKHOLM, Jan. 16, 2026 /PRNewswire/ -- Sobi® (STO: SOBI), today announced that the European Commission (EC) has approved...
Themefolio
Profiler
Peergroup
© Globe Newswire
16.01.2026
ATAI
LISTED
NASDAQ
AtaiBeckley Participates in the 64th Annual ACNP Meeting with Two Scientific Poster Presentations and Hot Topic Presentation
News Preview
AtaiBeckley announced participation in the 64th Annual Meeting of the American College of Neuropsychopharmacology (ACNP)...
Themefolio
Profiler
Peergroup
© Globe Newswire
16.01.2026
ORNBV
LISTED
HEL
182,827 Orion Corporation A shares converted into B shares
News Preview
ORION CORPORATION STOCK EXCHANGE RELEASE – OTHER INFORMATION DISCLOSED ACCORDING TO THE RULES OF THE EXCHANGE 16 JANUARY 2026 at 9:30 EET ...
Themefolio
Profiler
Peergroup
© PR Newswire
15.01.2026
CU6
LISTED
ASX
SECuRE trial to continue with no modifications to protocol following Safety Review Committee meeting
News Preview
HIGHLIGHTSFollowing an interim data review of the Cohort Expansion Phase (Phase II) of the SECuRE trial, the Safety Review Committee (SRC) confirms the trial will continue with no modifications to the protocol.Patient populationWith the SECuRE trial continuing to recruit, a total of nine participants who had evaluable data by the 25th of November...
Themefolio
Profiler
Peergroup
© Globe Newswire
15.01.2026
ORNBV
LISTED
HEL
Recommendation by the Orion Nomination Committee on the proposals to be presented to the 2026 Annual General Meeting
News Preview
ORION CORPORATION STOCK EXCHANGE RELEASE – OTHER INFORMATION DISCLOSED ACCORDING TO THE RULES OF THE EXCHANGE15 JANUARY 2026 at 16:30 EET...
Themefolio
Profiler
Peergroup
© Globe Newswire
14.01.2026
ORNBV
LISTED
HEL
Orion updates time estimate for the potential related to the annual Nubeqa® net sales recorded by Orion
News Preview
ORION CORPORATION STOCK EXCHANGE RELEASE 14 JANUARY 2026 at 16:00 EET ...
Themefolio
Profiler
Peergroup
© PR Newswire
14.01.2026
ACB
LISTED
NASDAQ
Aurora Achieves Significant Progress in Disease Resistance Research
News Preview
NASDAQ | TSX: ACBAs a leading global medical cannabis company, advancements in breeding, testing and production trials for powdery mildew-resistant cultivars reinforce Aurora's leadership in cannabis scienceEDMONTON, AB, Jan. 14, 2026 /CNW/ - Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical cannabis company,...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© PR Newswire
14.01.2026
ACB
LISTED
NASDAQ
Aurora Achieves Significant Progress in Disease Resistance Research
News Preview
NASDAQ | TSX: ACBAs a leading global medical cannabis company, advancements in breeding, testing and production trials for powdery mildew-resistant cultivars reinforce Aurora's leadership in cannabis scienceEDMONTON, AB, Jan. 14, 2026 /PRNewswire/ - Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical cannabis c...
Themefolio
Profiler
Peergroup
© EQS Newswire
14.01.2026
SRT3
LISTED
XETR
Mehr Produkte aus erneuerbaren Rohstoffen
News Preview
Göttingen, 14. Januar 2026
Nachhaltigkeitszertifikat für Standort Göttingen:
Mehr Produkte aus erneuerbaren Rohstoffen
Produktionsstandorte in Göttingen, Deutschland, und Mohamdia, Tunesien nach ISCC Plus zertifiziert
Biobasierte Rohstoffe reduzieren Anteil fossiler Kunststoffe in Filtern und Einwegbeuteln deutlich
Zertifiziertes Produktionsne......
Themefolio
Profiler
Peergroup
© PR Newswire
14.01.2026
SOBI
LISTED
STO
Invitation: Sobi's Q4 and FY 2025 report
News Preview
STOCKHOLM, Jan. 14, 2026 /PRNewswire/ -- Sobi plans to publish its report for the fourth quarter and full year of 2025 on 5 February 2026 at 08:00 CET.
Investors, analysts, and the media are invited to a conference call on the same day at 13:00 CET, 12:00 GMT, and 07:00 EST. The call will include a presentation of the results and a Q&A session...
Themefolio
Profiler
Peergroup
© Globe Newswire
14.01.2026
ORNBV
LISTED
HEL
Inside information: Orion provides outlook for 2026 and estimates that the annual Nubeqa® net sales recorded by Orion has potential to exceed EUR 1 billion in the future
News Preview
ORION CORPORATION STOCK EXCHANGE RELEASE – INSIDE INFORMATION 14 JANUARY 2026 at 8:30 EET ...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
14.01.2026
SRT3
LISTED
XETR
Sartorius Expands Bio-Circular Product Offering for More Sustainable Bioprocesses
News Preview
Further production hubs in Germany and Tunisia now certified by International Sustainability and Carbon CertificationCertified raw materials significantly reduce dependence on fossil-based plasticsBio-circular filters and additional single-use fluid management technologies now available for biopharma manufacturersCertified production network spans...
Themefolio
Profiler
Peergroup
© BusinessWire
13.01.2026
BAYN
LISTED
XETR
Bayer Accelerates Pharma Growth on High-Value Portfolio
News Preview
On the occasion of the 44th J.P. Morgan Healthcare Conference in San Francisco, Bayer AG today unveiled the strategic focus for its Pharmaceuticals Division in 2026.
Capitalizing on new launch momentum, the company will drive significant global regulatory expansions and market penetration across its pharmaceutical portfolio. High-value commercia...
Themefolio
Profiler
Peergroup
© ActuNews
13.01.2026
OXUR
LISTED
EURONEXT
Oxurion ontvangt transparantiekennisgeving van Atlas Special Opportunities II LLC
News Preview
Leuven, BELGIË – 13 januari 2026 – 18u00 CET Oxurion NV (Euronext Brussel: OXUR), een bedrijf met hoofdkantoor in Leuven, België, heeft vandaag aangekondigd dat het, in overeenstemming met de Belgische transparantiewetgeving1, de volgende transparantiekennisgeving heeft ontvangen:
Oxurion ontving een transparantiekennisgeving...
Themefolio
Profiler
Peergroup
© ActuNews
13.01.2026
OXUR
LISTED
EURONEXT
Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC
News Preview
Leuven, BELGIUM – January 13, 2026 – 06:00 PM CET - Oxurion NV (Euronext Brussels: OXUR), a company headquartered in Leuven, today announced that, pursuant to Belgian Transparency legislation1 it has received a transparency notification as follows:
Oxurion received a transparency notification on January 9, 2026, from Atlas Special Oppor...
Themefolio
Profiler
Peergroup
© Globe Newswire
13.01.2026
GNFT
LISTED
EURONEXT
GENFIT : Bilan semestriel du contrat de liquidité contracté avec le Crédit Industriel et Commercial
News Preview
Lille (France), Cambridge (Massachusetts, États-Unis), Zurich (Suisse), le 13 janvier 2026 – GENFIT (Euronext: GNFT), société biopharmaceutique de stade clinique avancé engagée dans l’amélioration de la vie des patients atteints de maladies rares du foie pouvant engager le pronostic vital, annonce aujourd’hui le bilan semestriel du contrat de liqui...
Themefolio
Profiler
Peergroup
© BusinessWire
13.01.2026
BAYN
LISTED
XETR
Actress and Menopause Advocate Gabrielle Union-Wade Partners with Bayer in the Lynkuet® (elinzanetant) ‘Life Doesn’t Stop for a Hot Flash’ Campaign for Moderate to Severe Hot Flashes Due to Menopause
News Preview
Bayer today announced it has partnered with actress and menopause advocate Gabrielle Union-Wade on the ‘Life Doesn’t Stop for a Hot Flash’ campaign, which speaks to women with moderate to severe hot flashes due to menopause. The campaign encourages women to have an open and honest conversation with their healthcare provider about their hot flash e...
Themefolio
Profiler
Peergroup
© Globe Newswire
13.01.2026
ORNBV
LISTED
HEL
Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)
News Preview
ORION CORPORATION STOCK EXCHANGE RELEASE / MAJOR SHAREHOLDER ANNOUNCEMENTS13 January 2026 at 16.30 EET ...
Themefolio
Profiler
Peergroup
© BusinessWire
13.01.2026
ZLAB
LISTED
NASDAQ
Zai Lab Highlights Strategic Priorities and Global Pipeline Progress at 44th Annual J.P. Morgan Healthcare Conference
News Preview
Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today provided an update on the Company’s 2026 strategic priorities and clinical development progress. These updates will be discussed as part of the Company’s presentation at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco on Tuesday, January 13, 2026, at 3:00 p.m. PT / 6:00 p.m. ET....
Themefolio
Profiler
Peergroup
© PR Newswire
13.01.2026
REC
LISTED
EURONEXT
ISTURISA® (osilodrostat) Now Available in Canada for the Treatment of Cushing's Disease
News Preview
ISTURISA® (osilodrostat) is indicated for the treatment of adult patients with Cushing's disease who have persistent or recurrent hypercortisolism after primary pituitary surgery and/or irradiation, or for whom pituitary surgery is not an option.1TORONTO, Jan. 13, 2026 /CNW/ - Recordati Rare Diseases Canada Inc. announced today the Canadian produc...
Themefolio
Profiler
Peergroup
© Globe Newswire
13.01.2026
TRAW
LISTED
NASDAQ
Traws Pharma Files Tivoxavir Marboxil Investigational New Drug (IND) Application for Influenza Therapy, and Provides Updated Results from the Ongoing Clinical Study of Ratutrelvir in PAXLOVID®-Eligible and Ineligible COVID-19 Patients
News Preview
IND filing of tivoxavir marboxil represents final step for formal consideration by the Center for the Biomedical Advanced Research and Development Authority (BARDA) for inclusion in strategic stockpile...
Themefolio
Profiler
Peergroup
© Globe Newswire
13.01.2026
KDEV
LISTED
STO
The subscription period in Karolinska Development AB (publ)’s rights issue begins today
News Preview
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, BELARUS, CANADA, JAPAN, NEW ZEALAND, RUSSIA, SWITZERLAND, SINGAPORE, SOUTH KOREA, SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. THIS PRESS RELEASE DOES NOT CONSTITUTE AN OFFER...
Themefolio
Profiler
Peergroup
© BusinessWire
12.01.2026
ASRT
LISTED
NASDAQ
Assertio Holdings, Inc. Regains Compliance With Nasdaq Listing Requirements
News Preview
Assertio Holdings, Inc. (“Assertio” or the “Company”) (NASDAQ: ASRT) today announced that it has received confirmation from The Nasdaq Stock Market LLC (“Nasdaq”) that the Company has regained compliance with all applicable listing requirements.
As of January 12, 2026, Nasdaq has determined that Assertio has regained compliance with the Minimum...
Themefolio
Profiler
Peergroup
© Globe Newswire
12.01.2026
IBAB
LISTED
EURONEXT
IBA – TRANSPARENCY NOTIFICATION
News Preview
(Article 14, paragraph 1 of the law of 2 May 2007 on the disclosure of major holdings)...
Themefolio
Profiler
Peergroup
© Globe Newswire
12.01.2026
IBAB
LISTED
EURONEXT
IBA – TRANSPARENCY NOTIFICATION
News Preview
(Article 14, paragraph 1 of the law of 2 May 2007 on the disclosure of major holdings)...
Themefolio
Profiler
Peergroup
© BusinessWire
12.01.2026
ERF
LISTED
EURONEXT
Eurofins Scientific: Director/PDMR Shareholding
News Preview
Eurofins Scientific SE (EUFI.PA) (Paris:ERF) has received various notifications of dealing from Persons Discharging Managerial Responsibilities (“PDMR”). The notification of Dealing Form for each PDMR can be found below.
This notification is made in accordance with the European Market Abuse Regulation.
NOTIFICATION AND PUBLIC DISCLOSURE OF T...
Themefolio
Profiler
Peergroup
© EQS Newswire
12.01.2026
EUZ
LISTED
XETR
Eckert & Ziegler präsentiert auf der 44. Annual J.P. Morgan Healthcare Conference
News Preview
Berlin, 12. Januar 2026. Die Eckert & Ziegler SE (ISIN DE0005659700, TecDAX) wird an der 44. Annual J.P. Morgan Healthcare Conference am Mittwoch, den 14. Januar 2026, im Westin St. Francis in San Francisco, CA, USA, teilnehmen. Dr. Harald Hasselmann, Vorstandsvorsitzender der Eckert & Ziegler SE, wird das Unternehmen um 17:15 PST präsentie......
Themefolio
Profiler
Peergroup
© EQS Newswire
12.01.2026
EUZ
LISTED
XETR
Eckert & Ziegler to Participate in the 44th Annual J.P. Morgan Healthcare Conference
News Preview
Berlin, 12 January 2026. Eckert & Ziegler SE (ISIN DE0005659700, TecDAX) will participate in the 44th Annual J.P. Morgan Healthcare Conference on Wednesday, 14 January 2026, at the Westin St. Francis in San Francisco, CA, USA. Dr Harald Hasselmann, CEO of Eckert & Ziegler SE, will present the company at 17:15 PST.
The presentation will be a......
Themefolio
Profiler
Peergroup
© BusinessWire
12.01.2026
TEM
LISTED
NASDAQ
Tempus and NYU Langone Health Announce Strategic Collaboration to Advance Precision Oncology
News Preview
Tempus, a leader in artificial intelligence and precision medicine, and NYU Langone Health, one of the nation’s premier academic medical centers, today announced a multi-year strategic collaboration aimed at transforming cancer care through advanced molecular profiling and data-driven insights. The collaboration will support NYU Langone Health’s C...
Themefolio
Profiler
Peergroup
© BusinessWire
12.01.2026
BAYN
LISTED
XETR
Bayer to Expand Into Molecular Imaging With Acquisition of Innovative Pan-Amyloid Radiotracers From Attralus
News Preview
Bayer, a leading company in key areas of radiology and cardiology, and Attralus, Inc. (Attralus), a clinical stage biopharmaceutical company focused on developing medicines and diagnostics for systemic amyloidosis, today announced that the companies have entered into definitive agreements for Bayer to acquire AT-01 (124-Iodine-evuzamitide) and AT-...
Themefolio
Profiler
Peergroup
© PR Newswire
12.01.2026
KPTI
LISTED
NASDAQ
Karyopharm Announces Preliminary Unaudited 2025 Revenue and Reiterates Expectation of Delivering Potentially Transformative Phase 3 Data in 2026
News Preview
– Top-Line Data from the Phase 3 SENTRY Trial in Myelofibrosis on Track for March 2026 –– Top-Line Data from the Phase 3 XPORT-EC-042 Trial in Endometrial Cancer on Track for Mid-2026 –– Preliminary Unaudited Full Year 2025 Total Revenue and U.S. XPOVIO® (selinexor) Net Product Revenue Expected to be Approximately $145 Million and $115 Million, Re...
Themefolio
Profiler
Peergroup
© Globe Newswire
12.01.2026
ORNBV
LISTED
HEL
Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)
News Preview
ORION CORPORATION STOCK EXCHANGE RELEASE / MAJOR SHAREHOLDER ANNOUNCEMENTS12 January 2026 at 15:00 EET ...
Themefolio
Profiler
Peergroup
© BusinessWire
12.01.2026
TEM
LISTED
NASDAQ
Northwestern Medicine Selects Tempus to Expand Genomic Testing
News Preview
Northwestern Medicine and Tempus AI, Inc. (NASDAQ: TEM) are collaborating to expand access to genomic testing for Northwestern Medicine cancer patients. The goal is to provide nearly every patient across cancer types, including patients with early-stage cancer diagnoses, access to genomic testing. Patients will benefit from a deeper understanding...
Themefolio
Profiler
Peergroup
© PR Newswire
12.01.2026
NUTX
LISTED
NASDAQ
NUTEX HEALTH RE-OPENS BAYOU CITY ER & HOSPITAL IN HOUSTON
News Preview
HOUSTON, Jan. 12, 2026 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, integrated healthcare delivery system comprised of 27 state-of-the-art micro hospitals and hospital outpatient departments in 12 states and primary care-centric, risk-bearing physician networks, today announced the reopening...
Themefolio
Profiler
Peergroup
© Newsfile
12.01.2026
COPN
LISTED
SIX
Cosmo Enters Scale Up Phase with 104M Revenue, 128M Cash, and Breakout AI and Dermatology Platforms
News Preview
Ad hoc announcement pursuant to Art. 53 LR 2025 marks a key execution year in Cosmo’s Vision 2030, strengthening the Company’s foundations for scalable, innovation-driven growth across AI-enabled MedTech and pharma. Financial Highlights: High quality growth: €104 million revenue...
Themefolio
Profiler
Peergroup
© Globe Newswire
12.01.2026
FAGR
LISTED
EURONEXT
Inside information: Fagron announces the completion of the acquisition of University Compounding Pharmacy in North America
News Preview
Regulated information - inside informationNazareth (Belgium)/Rotterdam (The Netherlands), 12 January 2026 – 7:00 AM CET...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
12.01.2026
CLBX
LISTED
AIMX
CelLBxHealth PLC Announces Board Changes
News Preview
GUILDFORD, SURREY / ACCESS Newswire / January 12, 2026 / CelLBxHealth plc (AIM:CLBX), a leader in circulating tumour cell (CTC) intelligence, with tests and services supporting research, drug development and clinical oncology, is pleased to announce that further to the announcement of 15 December 2025, that the following have been appointed to the...
Themefolio
Profiler
Peergroup
© BusinessWire
11.01.2026
TEM
LISTED
NASDAQ
Tempus Achieves Record Total Contract Value Exceeding $1.1 Billion
News Preview
Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced a record Total Contract Value (TCV) of >$1.1 billion as of December 31, 2025. During 2025, Tempus signed data agreements with over 70 customers, spanning both large and mid-sized pharma, including AstraZeneca, GlaxoSmith...
Themefolio
Profiler
Peergroup
© BusinessWire
11.01.2026
TEM
LISTED
NASDAQ
Tempus Announces Preliminary Fourth Quarter and Full Year 2025 Results
News Preview
Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced select, preliminary, unaudited results for the fourth quarter and full year ended December 31, 2025.
Full Year 2025 Select, Preliminary, Unaudited Financial Results
Revenue of ~$1.27 billion, representing ~83% growth y...
Themefolio
Profiler
Peergroup
© BusinessWire
09.01.2026
SKYE
LISTED
NASDAQ
SKYE Deadline: Rosen Law Firm Urges Skye Bioscience, Inc. (NASDAQ: SKYE) Stockholders to Contact the Firm for Information About Their Rights
News Preview
Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Skye Bioscience, Inc. (NASDAQ: SKYE) between November 4, 2024 and October 3, 2025. Skye is a clinical stage biopharmaceutical company.
For more information, submit a form, email attorney Phillip Kim, or give us a call at 866-767-3653.
The Allegations: Rosen...
Themefolio
Profiler
Peergroup
© Globe Newswire
09.01.2026
ASND
LISTED
NASDAQ
Ascendis Pharma Provides Business and Strategic Roadmap Update at 44th Annual J.P. Morgan Healthcare Conference
News Preview
- Rapidly transforming into a leading global biopharma company - Rapidly transforming into a leading global biopharma company...
Themefolio
Profiler
Peergroup
© BusinessWire
09.01.2026
ASRT
LISTED
NASDAQ
Assertio Announces Publication of Rolvedon® Same-Day Dosing Clinical Trial
News Preview
Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT) today announced that results of a clinical trial investigating a novel dosing schedule of Rolvedon® (eflapegrastim-xnst) injection have been peer reviewed and published in The Oncologist.
In the study of patients with early-stage breast cancer (ESBC), Rolvedon, when administere...
Themefolio
Profiler
Peergroup
© Globe Newswire
09.01.2026
FAGR
LISTED
EURONEXT
Disclosure of notification received from BNP Paribas
News Preview
Regulated information Nazareth (Belgium)/Rotterdam (The Netherlands), 09 January 2026 – 5:40 PM CET...
Themefolio
Profiler
Peergroup
© PR Newswire
09.01.2026
CAMX
LISTED
STO
Camurus announces FDA acceptance of NDA resubmission for Oclaiz™ for the treatment of acromegaly
News Preview
PDUFA target action date set to 10 June 2026 LUND, Sweden, Jan. 9, 2026 /PRNewswire/ -- Camurus (NASDAQ STO: CAMX) today announced that the U.S. Food and Drug Administration (FDA) has accepted for review the company's resubmission of the New Drug Application (NDA) for Oclaiz™ (CAM2029), octreotide extended-release injection, for the treatment of p...
Themefolio
Profiler
Peergroup
© PR Newswire
09.01.2026
CAMX
LISTED
STO
Camurus announces FDA acceptance of NDA resubmission for Oclaiz™ for the treatment of acromegaly
News Preview
PDUFA target action date set to 10 June 2026 LUND, Sweden, Jan. 9, 2026 /PRNewswire/ -- Camurus (NASDAQ STO: CAMX) today announced that the U.S. Food and Drug Administration (FDA) has accepted for review the company's resubmission of the New Drug Application (NDA) for Oclaiz™ (CAM2029), octreotide extended-release injection, for the treatment of p...
Themefolio
Profiler
Peergroup
© Globe Newswire
09.01.2026
ORNBV
LISTED
HEL
Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)
News Preview
ORION CORPORATION STOCK EXCHANGE RELEASE / MAJOR SHAREHOLDER ANNOUNCEMENTS9 January 2026 at 16:00 EET ...
Themefolio
Profiler
Peergroup
© Globe Newswire
09.01.2026
MDGL
LISTED
NASDAQ
Madrigal Expands its MASH Pipeline with Exclusive Global License Agreement for Ervogastat, a Phase 2 Oral DGAT-2 Inhibitor
News Preview
CONSHOHOCKEN, Pa., Jan. 09, 2026 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL), a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), today announced an exclusive global license agreement with Pfizer for ervogastat, a clinical-stage oral DGAT-2 inhibit...
Themefolio
Profiler
Peergroup
© Globe Newswire
09.01.2026
IMCR
LISTED
NASDAQ
Immunocore announces 2026 strategic priorities at 44th Annual J.P. Morgan Healthcare Conference
News Preview
Immunocore announces 2026 strategic priorities at 44th Annual J.P. Morgan Healthcare Conference...
Themefolio
Profiler
Peergroup
© Globe Newswire
09.01.2026
KDEV
LISTED
STO
Karolinska Development AB (publ) announces publication of information document in connection with upcoming rights issue
News Preview
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, BELARUS, CANADA, JAPAN, NEW ZEALAND, RUSSIA, SWITZERLAND, SINGAPORE, SOUTH KOREA, SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. THIS PRESS RELEASE DOES NOT CONSTITUTE AN OFFER...
Themefolio
Profiler
Peergroup
© EQS Newswire
09.01.2026
FME
LISTED
XETR
Fresenius Medical Care AG setzt Aktienrückkaufprogramm beschleunigt fort
News Preview
Bad Homburg, 9. Januar 2026 – Die Fresenius Medical Care AG („Gesellschaft“) hat entschieden, den Rückerwerb der zweiten Tranche des mit einer Ad-hoc-Mitteilung vom 17. Juni 2025 bekanntgegebenen Aktienrückkaufprogramms zu starten. Das Aktienrückkaufprogramm hat ein Volumen von insgesamt EUR 1 Milliarde (ohne Erwerbsnebenkosten).
Die erste Tranche......
Themefolio
Profiler
Peergroup
© Globe Newswire
09.01.2026
ZEAL
LISTED
CPH
Zealand Pharma enters agreement with DCAI to use Gefion AI supercomputer to accelerate drug discovery and support Metabolic Frontier 2030 strategy
News Preview
Press release – No. 2 / 2026...
Themefolio
Profiler
Peergroup
© Globe Newswire
08.01.2026
ANAB
LISTED
NASDAQ
Anaptys Files Motion to Dismiss Tesaro’s Claim of Anticipatory Breach of Contract in Ongoing Litigation Against Tesaro, a GSK subsidiary
News Preview
SAN DIEGO, Jan. 08, 2026 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company focused on delivering innovative immunology therapeutics, filed a partial motion to dismiss Tesaro’s anticipatory breach of contract claim in Delaware Chancery Court related to pending litigation between Anaptys, GSK, and TESARO, I...
Themefolio
Profiler
Peergroup
© BusinessWire
08.01.2026
SLP
LISTED
NASDAQ
Simulations Plus Reports First Quarter Fiscal 2026 Financial Results
News Preview
Simulations Plus, Inc. (Nasdaq: SLP) (“Simulations Plus” or the “Company”), a global leader in model-informed and AI-accelerated drug development that advances biopharma innovation, today reported financial results for its first quarter fiscal 2026, ended November 30, 2025.
First Quarter 2026 Financial Highlights (as compared to first quarter 20...
Themefolio
Profiler
Peergroup
© ActuNews
08.01.2026
ALTHX
LISTED
EURONEXT
THERANEXUS : THX Pharma announces the publication of its letter to shareholders
News Preview
Lyon, France – January 8, 2025, 6:00 PM CET – THX Pharma (Theranexus), an innovative biopharmaceutical company in the treatment of rare neurological diseases, today announces the publication of its letter to shareholders.
To download the newsletter, click here.
This letter is also available on the Theranexus website (link), in the Shar...
Themefolio
Profiler
Peergroup
© ActuNews
08.01.2026
ALTHX
LISTED
EURONEXT
THERANEXUS : THX Pharma annonce la publication de sa lettre aux actionnaires
News Preview
Lyon, France – 8 janvier 2026, 18h CET – THX Pharma (Theranexus), société biopharmaceutique innovante dans le traitement des maladies neurologiques rares, annonce ce jour la publication de sa lettre aux actionnaires.
Pour télécharger la newsletter, cliquez ici
Cette lettre est également consultable sur...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
